Showing 1-10 of about 49 articles.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals to Present at UBS Global Healthcare Conference
DUBLIN, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at the 2013 UBS Global Healthcare Conference on Monday May 20
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals to Present at Needham Healthcare Conference
DUBLIN, Calif., April 23, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at the Needham 12th Annual Healthcare Conference on Tuesday April 30
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals to Announce 2013 First Quarter Financial Results on April 29th
DUBLIN, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that it will release its 2013 first quarter results on Monday, April 29, 2013. James S.J. Manuso, PhD, chairman and chief executive officer, and the Astex Pharmaceuticals management team will provide details of the Company's first quarter activities.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals Pipeline Data Presentations at AACR
DUBLIN, Calif., April 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the acceptance of thirteen abstracts covering internal and partner funded pipeline product data for poster or oral presentation at the American Association for Cancer Research (AACR) Annual Meeting April 6 to 10, 2013 in Washington, DC.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals to Present at ROTH Conference
DUBLIN, Calif., March 12, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at the 25th Annual ROTH Conference on Tuesday March 19
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
DUBLIN, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that Mohammad Azab, MD, chief medical officer, and Michael Molkentin, chief financial officer, will present at the 2013 RBC Capital Markets Healthcare Conference on Wednesday, February 27
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals to Announce 2012 Fourth Quarter and Year-End Financial Results on February 25th
DUBLIN, Calif., Feb. 19, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that it will release its 2012 fourth quarter and fiscal year-end results on Monday, February 25, 2013. James S.J. Manuso, PhD, chairman and chief executive officer, and the Astex Pharmaceuticals management team will provide details of the Company's financial results for fiscal year 2012.
Showing 1-10 of about 49 articles.